References
- BIRZU C, TRAN S, BIELLE F, TOUAT M, MOKHTARI K, YOUNAN N, et al. Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges. Oncologist. 2020;25(11):e1763–e1776.
- LOUIS DN, PERRY A, WESSELING P, BRAT DJ, CREE IA, FIGARELLABRANGER D, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro. Oncol. 2021;23:1231–1251.
- NOH JH, LEE MH, KIM WS, LIM DH, KIM ST, KONG DS, et al. Optimal treatment of leptomeningeal spread in glioblastoma: analysis of risk factors and outcome. Acta Neurochir. (Wien). 2015;157:569–576.
- WANG N, BERTALAN MS, BRASTIANOS PK. Leptomeningeal metastasis from systemic cancer: Review and update on management. Cancer [Internet] 2018; 124: 21–35.
- NAYAR G, EJIKEME T, CHONGSATHIDKIET P, ELSAMADICY AA, BLACKWELL KL, CLARKE JM, et al. Leptomeningeal disease: current diagnostic and therapeutic strategies. Oncotarget. 2017;8(42):73312–73328.
- PAN Z, YANG G, HE H, YUAN T, WANG Y, LI Y, et al. Leptomeningeal metastasis from solid tumors: clinical features and its diagnostic implication. Sci Rep. 2018;8(1):10445.
- BÖNIG L, MÖHN N, AHLBRECHT J, WURSTER U, RAAB P, PUPPE W, et al. Leptomeningeal Metastasis: The Role of Cerebrospinal Fluid Diagnostics. Front Neurol. 2019;10:839.
- YUNG WKA, HORTEN BC, SHAPIRO WR. Meningeal gliomatosis: A review of 12 cases. Ann Neurol 1980;8:605–608.
- HO CY, VANDENBUSSCHE CJ, HUPPMAN AR, CHAUDHRY R, ALI SZ. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid. Cancer Cytopathol. 2015;123(2):123–35.
- DARDIS C, MILTON K, ASHBY L, SHAPIRO W. Leptomeningeal metastases in high-grade adult glioma: development, diagnosis, management, and outcomes in a series of 34 patients. Front Neurol. 2014;5:220.
- ANDERSEN BM, MIRANDA C, HATZOGLOU V, DEANGELIS LM, MILLER AM. Leptomeningeal metastases in glioma: The Memorial Sloan Kettering Cancer Center experience. Neurology. 2019;92(21):e2483–e2491.
- IJZERMAN-KOREVAAR M, SNIJDERS TJ, DE GRAEFF A, TEUNISSEN SCCM, DE VOS FYF. Prevalence of symptoms in glioma patients throughout the disease trajectory: a systematic review. J Neurooncol. 2018;140(3):485–496.